A $2.4-million grant was awarded to two Ottawa researchers for their work in fighting the chronic and often disabling disease of the brain and spinal cord that is multiple sclerosis.
Dr. Harry Atkins and Dr. Mark Freedman will continue a closely watched clinical trial involving an experimental bone marrow stem cell transplant therapy. Their team was awarded the money by The Multiple Sclerosis Society of Canada.
Improvements in the ability to walk and see have been among the most dramatic observations of their MS research along with data on MS symptoms slowing down.
“The idea behind this clinical trial is to replace the diseased immune system with a new one derived from the patient